

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 7.91329993 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26922532 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.26922532 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.13474857 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.99901826 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99901826 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.44750198 |
| 8 | * high-density lipoprotein particle remodeling (GO:0034375) | 5.83481083 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.76922758 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.74328698 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.74328698 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.74328698 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.70962182 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.69817855 |
| 15 | urea cycle (GO:0000050) | 5.66015011 |
| 16 | urea metabolic process (GO:0019627) | 5.66015011 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.62141096 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55920345 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.53169637 |
| 20 | * negative regulation of lipase activity (GO:0060192) | 5.50038505 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 5.41704138 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.41599129 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29487877 |
| 24 | protein carboxylation (GO:0018214) | 5.29487877 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.24058730 |
| 26 | cysteine metabolic process (GO:0006534) | 5.22291574 |
| 27 | * reverse cholesterol transport (GO:0043691) | 5.21815829 |
| 28 | epoxygenase P450 pathway (GO:0019373) | 5.19606652 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.19468684 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.11629805 |
| 31 | * macromolecular complex remodeling (GO:0034367) | 5.08479403 |
| 32 | * plasma lipoprotein particle remodeling (GO:0034369) | 5.08479403 |
| 33 | * protein-lipid complex remodeling (GO:0034368) | 5.08479403 |
| 34 | * regulation of cholesterol esterification (GO:0010872) | 5.01875754 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.97403173 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 4.96702688 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.96702688 |
| 38 | bile acid metabolic process (GO:0008206) | 4.92259987 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.90892160 |
| 40 | * phospholipid efflux (GO:0033700) | 4.84510920 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79521639 |
| 42 | regulation of complement activation (GO:0030449) | 4.73358129 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.69590159 |
| 44 | * triglyceride homeostasis (GO:0070328) | 4.62076535 |
| 45 | * acylglycerol homeostasis (GO:0055090) | 4.62076535 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.61786709 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.61038001 |
| 48 | * cholesterol efflux (GO:0033344) | 4.58186794 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.54860903 |
| 50 | * plasma lipoprotein particle clearance (GO:0034381) | 4.49830959 |
| 51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.49438605 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.49438605 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.46666816 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.41649432 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.41501900 |
| 56 | lysine catabolic process (GO:0006554) | 4.39370923 |
| 57 | lysine metabolic process (GO:0006553) | 4.39370923 |
| 58 | * plasma lipoprotein particle assembly (GO:0034377) | 4.32963001 |
| 59 | regulation of lipoprotein particle clearance (GO:0010984) | 4.32494568 |
| 60 | lipoprotein transport (GO:0042953) | 4.26139452 |
| 61 | * sterol transport (GO:0015918) | 4.23349096 |
| 62 | * cholesterol transport (GO:0030301) | 4.23349096 |
| 63 | diacylglycerol metabolic process (GO:0046339) | 4.18831801 |
| 64 | * regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.17089793 |
| 65 | glycine metabolic process (GO:0006544) | 4.16753292 |
| 66 | low-density lipoprotein particle remodeling (GO:0034374) | 4.16636486 |
| 67 | glutamate metabolic process (GO:0006536) | 4.14418630 |
| 68 | intestinal cholesterol absorption (GO:0030299) | 4.14144541 |
| 69 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.13095527 |
| 70 | exogenous drug catabolic process (GO:0042738) | 4.12785002 |
| 71 | drug catabolic process (GO:0042737) | 4.09534340 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.08033760 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 4.07877766 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.06658890 |
| 75 | fibrinolysis (GO:0042730) | 4.06249022 |
| 76 | coenzyme catabolic process (GO:0009109) | 4.05959738 |
| 77 | proline metabolic process (GO:0006560) | 4.04990287 |
| 78 | arginine metabolic process (GO:0006525) | 4.04602509 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 4.04472966 |
| 80 | cellular glucuronidation (GO:0052695) | 4.01445380 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.99468329 |
| 82 | drug metabolic process (GO:0017144) | 3.98919519 |
| 83 | * cholesterol homeostasis (GO:0042632) | 3.98465660 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.98461137 |
| 85 | negative regulation of hemostasis (GO:1900047) | 3.97770210 |
| 86 | negative regulation of blood coagulation (GO:0030195) | 3.97770210 |
| 87 | amine catabolic process (GO:0009310) | 3.96991174 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.96991174 |
| 89 | L-ascorbic acid metabolic process (GO:0019852) | 3.95584602 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93627698 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 3.93272153 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.92157681 |
| 93 | * sterol homeostasis (GO:0055092) | 3.91812125 |
| 94 | * plasma lipoprotein particle organization (GO:0071827) | 3.90573155 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90560321 |
| 96 | intestinal absorption (GO:0050892) | 3.89445426 |
| 97 | * protein-lipid complex assembly (GO:0065005) | 3.88510838 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.87819390 |
| 99 | ketone body metabolic process (GO:1902224) | 3.86246244 |
| 100 | omega-hydroxylase P450 pathway (GO:0097267) | 3.84440332 |
| 101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.82730719 |
| 102 | * lipoprotein metabolic process (GO:0042157) | 3.79469992 |
| 103 | ethanol oxidation (GO:0006069) | 3.77697525 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.72257142 |
| 105 | flavonoid metabolic process (GO:0009812) | 3.71338348 |
| 106 | * protein-lipid complex subunit organization (GO:0071825) | 3.68209586 |
| 107 | negative regulation of protein activation cascade (GO:2000258) | 3.67637630 |
| 108 | negative regulation of coagulation (GO:0050819) | 3.66943143 |
| 109 | heme transport (GO:0015886) | 3.66569857 |
| 110 | acylglycerol catabolic process (GO:0046464) | 3.65992847 |
| 111 | neutral lipid catabolic process (GO:0046461) | 3.65992847 |
| 112 | cofactor catabolic process (GO:0051187) | 3.64879239 |
| 113 | * positive regulation of steroid metabolic process (GO:0045940) | 3.62655404 |
| 114 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.61852371 |
| 115 | protein activation cascade (GO:0072376) | 3.61659546 |
| 116 | organic acid catabolic process (GO:0016054) | 3.60772524 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.60772524 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.60272004 |
| 119 | glucuronate metabolic process (GO:0019585) | 3.56008235 |
| 120 | uronic acid metabolic process (GO:0006063) | 3.56008235 |
| 121 | acute-phase response (GO:0006953) | 3.55724046 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.54321438 |
| 123 | regulation of plasminogen activation (GO:0010755) | 3.52296083 |
| 124 | complement activation (GO:0006956) | 3.50743065 |
| 125 | negative regulation of wound healing (GO:0061045) | 3.46318521 |
| 126 | phenylpropanoid metabolic process (GO:0009698) | 3.44820057 |
| 127 | negative regulation of lipid transport (GO:0032369) | 3.44244558 |
| 128 | * regulation of cholesterol transport (GO:0032374) | 3.37289711 |
| 129 | * regulation of sterol transport (GO:0032371) | 3.37289711 |
| 130 | * lipid homeostasis (GO:0055088) | 3.35230592 |
| 131 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.26517811 |
| 132 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.22921932 |
| 133 | regulation of lipoprotein metabolic process (GO:0050746) | 3.16980266 |
| 134 | * regulation of cytokine secretion involved in immune response (GO:0002739) | 3.14804853 |
| 135 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.13430211 |
| 136 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.11918473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.26386178 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14202489 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.79215364 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42775500 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.20606401 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07343459 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.97064176 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95320886 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88252914 |
| 10 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20113222 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.18388102 |
| 12 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.07724659 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03066633 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9100949 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95658439 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93606794 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63712666 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63566415 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55137768 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52292755 |
| 21 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46490832 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45815302 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25225797 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18590912 |
| 25 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17190919 |
| 26 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16818513 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16575484 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12821113 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11313244 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10998329 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08755985 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08164755 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08078064 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02861283 |
| 35 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.01295793 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92806623 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91722069 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89161447 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87858163 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86445307 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86046558 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83200168 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82701356 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81871708 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80787388 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80710493 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78835716 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78566417 |
| 49 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77321953 |
| 50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76429876 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.76069899 |
| 52 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75770841 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75369280 |
| 54 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74931240 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73777049 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73534121 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72936013 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72698417 |
| 59 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.72472206 |
| 60 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72298188 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71797307 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70256514 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68639375 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67226230 |
| 65 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.67164914 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.66607612 |
| 67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65091922 |
| 68 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.64829827 |
| 69 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.64660074 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 0.64641921 |
| 71 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63430493 |
| 72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.63143457 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.62745520 |
| 74 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62709556 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62444468 |
| 76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.61539749 |
| 77 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.61248185 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60985174 |
| 79 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.60671492 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.60669071 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60478675 |
| 82 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.60174926 |
| 83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59401766 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.59100039 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57040010 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.56856563 |
| 87 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.56572535 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56210870 |
| 89 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56129799 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55949431 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55949431 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55546747 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55378400 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55189855 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55058546 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54894500 |
| 97 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54428769 |
| 98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.54351162 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.54155141 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54069748 |
| 101 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.53925021 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.53865155 |
| 103 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.53865155 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53770499 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53404922 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53369559 |
| 107 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.52759251 |
| 108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51040722 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49988881 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49324935 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49246819 |
| 112 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47754295 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47153165 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47032319 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46909813 |
| 116 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46846906 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46334824 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45639316 |
| 119 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44687244 |
| 120 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.42890926 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41871309 |
| 122 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40816714 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.40684250 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39303344 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38225965 |
| 126 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38124391 |
| 127 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37813280 |
| 128 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37357181 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36890405 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.36225339 |
| 131 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36081728 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35552922 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35370556 |
| 134 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35189862 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35087268 |
| 136 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.35074415 |
| 137 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34731670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25795175 |
| 2 | MP0005360_urolithiasis | 8.02041033 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36984138 |
| 4 | MP0005365_abnormal_bile_salt | 6.09427867 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04230096 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.02886209 |
| 7 | MP0003252_abnormal_bile_duct | 3.94153189 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.69433808 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.09001253 |
| 10 | MP0005083_abnormal_biliary_tract | 2.96185853 |
| 11 | * MP0009840_abnormal_foam_cell | 2.94497390 |
| 12 | MP0005332_abnormal_amino_acid | 2.74083448 |
| 13 | MP0003195_calcinosis | 2.60666176 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.28793874 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.16575146 |
| 16 | * MP0002118_abnormal_lipid_homeostasis | 2.10474416 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.88732713 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.87330770 |
| 19 | MP0003868_abnormal_feces_composition | 1.86541930 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.79357239 |
| 21 | MP0003122_maternal_imprinting | 1.69858317 |
| 22 | MP0009697_abnormal_copulation | 1.68518101 |
| 23 | MP0001764_abnormal_homeostasis | 1.68240817 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54799900 |
| 25 | * MP0003191_abnormal_cellular_cholesterol | 1.54245985 |
| 26 | MP0005451_abnormal_body_composition | 1.52393710 |
| 27 | MP0003011_delayed_dark_adaptation | 1.47591104 |
| 28 | MP0008004_abnormal_stomach_pH | 1.42585554 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.39589352 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.38748031 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.28548027 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.24210413 |
| 33 | MP0004272_abnormal_basement_membrane | 1.19725587 |
| 34 | MP0000604_amyloidosis | 1.19353177 |
| 35 | MP0003186_abnormal_redox_activity | 1.16945242 |
| 36 | MP0003315_abnormal_perineum_morphology | 1.16792165 |
| 37 | MP0002254_reproductive_system_inflammat | 1.16279965 |
| 38 | * MP0000598_abnormal_liver_morphology | 1.16065387 |
| 39 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14222916 |
| 40 | MP0003123_paternal_imprinting | 1.06294416 |
| 41 | MP0009764_decreased_sensitivity_to | 1.03368170 |
| 42 | MP0000566_synostosis | 1.02992033 |
| 43 | MP0005647_abnormal_sex_gland | 0.99661836 |
| 44 | MP0009763_increased_sensitivity_to | 0.99104615 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.97581312 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.97008327 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.95256756 |
| 48 | MP0003183_abnormal_peptide_metabolism | 0.93593521 |
| 49 | MP0003879_abnormal_hair_cell | 0.92355582 |
| 50 | * MP0009642_abnormal_blood_homeostasis | 0.89836643 |
| 51 | MP0008469_abnormal_protein_level | 0.89717640 |
| 52 | MP0005367_renal/urinary_system_phenotyp | 0.88956586 |
| 53 | MP0000516_abnormal_urinary_system | 0.88956586 |
| 54 | MP0003941_abnormal_skin_development | 0.83534430 |
| 55 | MP0000537_abnormal_urethra_morphology | 0.82017081 |
| 56 | MP0005408_hypopigmentation | 0.81847156 |
| 57 | MP0002876_abnormal_thyroid_physiology | 0.79779921 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.79681645 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.79375849 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.79227450 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 0.77901191 |
| 62 | MP0006054_spinal_hemorrhage | 0.76941177 |
| 63 | * MP0005376_homeostasis/metabolism_phenot | 0.76390041 |
| 64 | MP0008260_abnormal_autophagy | 0.76236180 |
| 65 | MP0009053_abnormal_anal_canal | 0.75224426 |
| 66 | MP0002089_abnormal_postnatal_growth/wei | 0.73690346 |
| 67 | MP0002971_abnormal_brown_adipose | 0.71797195 |
| 68 | MP0005409_darkened_coat_color | 0.70633408 |
| 69 | MP0005334_abnormal_fat_pad | 0.68349678 |
| 70 | MP0005448_abnormal_energy_balance | 0.68264153 |
| 71 | MP0005266_abnormal_metabolism | 0.67294078 |
| 72 | MP0002090_abnormal_vision | 0.67009406 |
| 73 | MP0002822_catalepsy | 0.66960271 |
| 74 | MP0005670_abnormal_white_adipose | 0.66827283 |
| 75 | MP0005410_abnormal_fertilization | 0.65397162 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.65333325 |
| 77 | MP0003329_amyloid_beta_deposits | 0.65219585 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.62647318 |
| 79 | MP0001915_intracranial_hemorrhage | 0.61878450 |
| 80 | MP0003690_abnormal_glial_cell | 0.61310572 |
| 81 | MP0005535_abnormal_body_temperature | 0.61300376 |
| 82 | MP0001756_abnormal_urination | 0.61023556 |
| 83 | MP0004130_abnormal_muscle_cell | 0.57639325 |
| 84 | MP0003718_maternal_effect | 0.55906577 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 0.55789662 |
| 86 | MP0001661_extended_life_span | 0.53358540 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.50578886 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.50545991 |
| 89 | MP0005395_other_phenotype | 0.50371354 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.50102235 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.49745933 |
| 92 | MP0010030_abnormal_orbit_morphology | 0.46591830 |
| 93 | MP0008873_increased_physiological_sensi | 0.46431059 |
| 94 | MP0002796_impaired_skin_barrier | 0.45651699 |
| 95 | MP0002938_white_spotting | 0.45416398 |
| 96 | MP0008872_abnormal_physiological_respon | 0.42832631 |
| 97 | MP0005166_decreased_susceptibility_to | 0.42540863 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.42486473 |
| 99 | MP0003953_abnormal_hormone_level | 0.42384142 |
| 100 | MP0003075_altered_response_to | 0.42305012 |
| 101 | MP0004270_analgesia | 0.42156505 |
| 102 | * MP0000639_abnormal_adrenal_gland | 0.42029339 |
| 103 | MP0003436_decreased_susceptibility_to | 0.41513623 |
| 104 | MP0003699_abnormal_female_reproductive | 0.40869417 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.40216917 |
| 106 | MP0008874_decreased_physiological_sensi | 0.40212346 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.40186013 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.39757646 |
| 109 | MP0003890_abnormal_embryonic-extraembry | 0.38443274 |
| 110 | MP0009115_abnormal_fat_cell | 0.37359673 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.37178485 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.36906957 |
| 113 | MP0002168_other_aberrant_phenotype | 0.36765576 |
| 114 | MP0004147_increased_porphyrin_level | 0.36352705 |
| 115 | MP0003119_abnormal_digestive_system | 0.35336975 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.34684451 |
| 117 | MP0003724_increased_susceptibility_to | 0.34612320 |
| 118 | MP0002928_abnormal_bile_duct | 0.33842399 |
| 119 | MP0009672_abnormal_birth_weight | 0.33814182 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.33255738 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.32989986 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.32854428 |
| 123 | MP0000920_abnormal_myelination | 0.32712503 |
| 124 | MP0002135_abnormal_kidney_morphology | 0.32185521 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.31872918 |
| 126 | MP0003878_abnormal_ear_physiology | 0.31579229 |
| 127 | MP0005377_hearing/vestibular/ear_phenot | 0.31579229 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.31563810 |
| 129 | MP0000579_abnormal_nail_morphology | 0.31521634 |
| 130 | MP0001881_abnormal_mammary_gland | 0.31181762 |
| 131 | MP0000462_abnormal_digestive_system | 0.30916341 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.30486882 |
| 133 | * MP0000249_abnormal_blood_vessel | 0.30410597 |
| 134 | MP0006082_CNS_inflammation | 0.28912790 |
| 135 | MP0002970_abnormal_white_adipose | 0.28504903 |
| 136 | MP0002132_abnormal_respiratory_system | 0.27296274 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.25826951 |
| 138 | MP0005023_abnormal_wound_healing | 0.24604560 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.24503058 |
| 140 | MP0000538_abnormal_urinary_bladder | 0.24278284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.35724053 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16363579 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.02192375 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.83491114 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60234075 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.49256908 |
| 7 | Xanthomatosis (HP:0000991) | 6.42821239 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.47131145 |
| 9 | Complement deficiency (HP:0004431) | 4.97134965 |
| 10 | Joint hemorrhage (HP:0005261) | 4.77168919 |
| 11 | * Hypolipoproteinemia (HP:0010981) | 4.69665374 |
| 12 | Hyperammonemia (HP:0001987) | 4.58949222 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.53507283 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49936740 |
| 15 | Epidermoid cyst (HP:0200040) | 4.41228005 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26804197 |
| 17 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24607718 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18667480 |
| 19 | Fat malabsorption (HP:0002630) | 4.16221250 |
| 20 | Ketosis (HP:0001946) | 4.15080857 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.14288464 |
| 22 | Hyperglycinemia (HP:0002154) | 4.13216946 |
| 23 | Hyperglycinuria (HP:0003108) | 3.98054835 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.93909632 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89009252 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.89009252 |
| 27 | Retinal atrophy (HP:0001105) | 3.84978962 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80090491 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77047540 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75216623 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.74329963 |
| 32 | Abnormality of complement system (HP:0005339) | 3.63490083 |
| 33 | * Hypoalphalipoproteinemia (HP:0003233) | 3.55282184 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.40480194 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36232889 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32143858 |
| 37 | Acanthocytosis (HP:0001927) | 3.17564304 |
| 38 | Spontaneous abortion (HP:0005268) | 3.14682315 |
| 39 | Joint swelling (HP:0001386) | 3.09640732 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08510151 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.97128970 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.95241210 |
| 43 | Abnormal delivery (HP:0001787) | 2.95066671 |
| 44 | Ketoacidosis (HP:0001993) | 2.94751382 |
| 45 | Nausea (HP:0002018) | 2.94386829 |
| 46 | Steatorrhea (HP:0002570) | 2.92312131 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.88917726 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.87175797 |
| 49 | Metabolic acidosis (HP:0001942) | 2.85237615 |
| 50 | Myocardial infarction (HP:0001658) | 2.77621828 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.72719981 |
| 52 | Skin nodule (HP:0200036) | 2.70230601 |
| 53 | Chronic hepatic failure (HP:0100626) | 2.68878356 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.67249179 |
| 55 | Malnutrition (HP:0004395) | 2.61094374 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.60736524 |
| 57 | Cholecystitis (HP:0001082) | 2.60736524 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.56156841 |
| 59 | Lethargy (HP:0001254) | 2.55404669 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55129252 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.55129252 |
| 62 | Vascular calcification (HP:0004934) | 2.54846942 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.53411514 |
| 64 | Cholelithiasis (HP:0001081) | 2.52132340 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.46229144 |
| 66 | Osteomalacia (HP:0002749) | 2.45950365 |
| 67 | Poikilocytosis (HP:0004447) | 2.44730745 |
| 68 | Glomerulonephritis (HP:0000099) | 2.43464106 |
| 69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37768084 |
| 70 | Abnormality of alanine metabolism (HP:0010916) | 2.37768084 |
| 71 | Hyperalaninemia (HP:0003348) | 2.37768084 |
| 72 | Gout (HP:0001997) | 2.36739762 |
| 73 | Increased serum pyruvate (HP:0003542) | 2.36199593 |
| 74 | Spastic diplegia (HP:0001264) | 2.36040522 |
| 75 | Irritability (HP:0000737) | 2.33647913 |
| 76 | Cerebral edema (HP:0002181) | 2.32278675 |
| 77 | Gingival bleeding (HP:0000225) | 2.32129708 |
| 78 | Esophageal varix (HP:0002040) | 2.27997703 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.25571651 |
| 80 | Mitral stenosis (HP:0001718) | 2.22691338 |
| 81 | Pancreatitis (HP:0001733) | 2.22494775 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.21806852 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.21806852 |
| 84 | Neonatal onset (HP:0003623) | 2.21197126 |
| 85 | Late onset (HP:0003584) | 2.20906946 |
| 86 | Menorrhagia (HP:0000132) | 2.18540102 |
| 87 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.17259609 |
| 88 | Pigmentary retinal degeneration (HP:0001146) | 2.15569573 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15132703 |
| 90 | Abnormality of carpal bone ossification (HP:0006257) | 2.14704845 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14456782 |
| 92 | Epistaxis (HP:0000421) | 2.13791064 |
| 93 | Thrombophlebitis (HP:0004418) | 2.13109984 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.12050194 |
| 95 | * Amyloidosis (HP:0011034) | 2.10592776 |
| 96 | Enlarged kidneys (HP:0000105) | 2.08670940 |
| 97 | Vomiting (HP:0002013) | 2.07881892 |
| 98 | Brushfield spots (HP:0001088) | 2.07554500 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 2.06983686 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.06153779 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05466577 |
| 102 | Generalized aminoaciduria (HP:0002909) | 2.03589308 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98607096 |
| 104 | Reticulocytosis (HP:0001923) | 1.97638905 |
| 105 | Abnormality of glycolysis (HP:0004366) | 1.97019760 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.96228534 |
| 107 | Hepatoblastoma (HP:0002884) | 1.95259058 |
| 108 | Opisthotonus (HP:0002179) | 1.94882768 |
| 109 | Abnormal tarsal ossification (HP:0008369) | 1.94102582 |
| 110 | Elevated alkaline phosphatase (HP:0003155) | 1.92501199 |
| 111 | Megaloblastic anemia (HP:0001889) | 1.91268896 |
| 112 | Rickets (HP:0002748) | 1.90813596 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.86584880 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.85574665 |
| 115 | Abnormality of vitamin B metabolism (HP:0004340) | 1.84940425 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.84431644 |
| 117 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84419566 |
| 118 | Widely patent fontanelles and sutures (HP:0004492) | 1.82711382 |
| 119 | Abnormality of urine glucose concentration (HP:0011016) | 1.81154618 |
| 120 | Glycosuria (HP:0003076) | 1.81154618 |
| 121 | Hypophosphatemic rickets (HP:0004912) | 1.80258464 |
| 122 | Nephritis (HP:0000123) | 1.79204997 |
| 123 | Confusion (HP:0001289) | 1.79021460 |
| 124 | Elevated hepatic transaminases (HP:0002910) | 1.78784237 |
| 125 | Renal cortical cysts (HP:0000803) | 1.76262828 |
| 126 | Proximal tubulopathy (HP:0000114) | 1.76161215 |
| 127 | Hyperphosphaturia (HP:0003109) | 1.74759974 |
| 128 | Gonadal dysgenesis (HP:0000133) | 1.70909344 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.69914446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.91580081 |
| 2 | ERN1 | 4.59429315 |
| 3 | FGFR4 | 4.43363898 |
| 4 | SIK1 | 4.20240405 |
| 5 | TAOK3 | 2.93341471 |
| 6 | TESK2 | 2.91690189 |
| 7 | ACVR1B | 2.75448967 |
| 8 | INSRR | 2.73403175 |
| 9 | MST1R | 2.73283415 |
| 10 | ERBB4 | 2.68981445 |
| 11 | CDK19 | 2.45528376 |
| 12 | LMTK2 | 2.39830096 |
| 13 | PKN2 | 2.18931586 |
| 14 | MAP2K4 | 2.16817033 |
| 15 | FRK | 2.08176899 |
| 16 | PDK2 | 10.7121205 |
| 17 | MAPK11 | 1.95230350 |
| 18 | MAP3K12 | 1.90015331 |
| 19 | TRIB3 | 1.86576820 |
| 20 | PTK6 | 1.83348036 |
| 21 | FLT3 | 1.78028454 |
| 22 | GRK6 | 1.77716245 |
| 23 | TYK2 | 1.71231835 |
| 24 | LATS1 | 1.61751488 |
| 25 | PIK3CG | 1.58806669 |
| 26 | DAPK2 | 1.46518064 |
| 27 | KDR | 1.39146518 |
| 28 | MAP3K10 | 1.38777948 |
| 29 | ABL2 | 1.37859093 |
| 30 | NEK9 | 1.29612787 |
| 31 | WNK4 | 1.23278164 |
| 32 | WNK3 | 1.20189171 |
| 33 | PRKAA2 | 1.18053150 |
| 34 | MAP3K7 | 1.15911438 |
| 35 | JAK2 | 1.15580371 |
| 36 | TBK1 | 1.15157070 |
| 37 | MET | 1.12463346 |
| 38 | PDGFRA | 1.11912820 |
| 39 | MAP3K11 | 1.11512741 |
| 40 | NEK2 | 1.10203677 |
| 41 | MAP2K3 | 1.09982841 |
| 42 | ERBB2 | 1.09003129 |
| 43 | MAP3K3 | 1.04538103 |
| 44 | EPHB1 | 1.04245967 |
| 45 | RIPK1 | 1.01942673 |
| 46 | FGFR2 | 1.01334224 |
| 47 | MUSK | 0.96881277 |
| 48 | MAPK4 | 0.93819367 |
| 49 | FGFR1 | 0.93574860 |
| 50 | JAK1 | 0.89017389 |
| 51 | PINK1 | 0.88712473 |
| 52 | PRKCZ | 0.84681698 |
| 53 | NTRK3 | 0.82911409 |
| 54 | MAP2K6 | 0.80683346 |
| 55 | CDK6 | 0.79249838 |
| 56 | FGR | 0.79002737 |
| 57 | PTK2 | 0.78968327 |
| 58 | DYRK1B | 0.78243000 |
| 59 | PRKACG | 0.78084946 |
| 60 | MAP3K14 | 0.76435143 |
| 61 | STK3 | 0.75667230 |
| 62 | STK38L | 0.73494441 |
| 63 | EPHA3 | 0.73411000 |
| 64 | CSK | 0.72841721 |
| 65 | CAMK2G | 0.71642850 |
| 66 | MAP2K2 | 0.71495292 |
| 67 | MAPK12 | 0.71106274 |
| 68 | TIE1 | 0.70837250 |
| 69 | TYRO3 | 0.68397677 |
| 70 | GSK3A | 0.66732144 |
| 71 | MATK | 0.65882753 |
| 72 | MAPK15 | 0.65201778 |
| 73 | PRKAA1 | 0.64767056 |
| 74 | EIF2AK3 | 0.64229673 |
| 75 | MYLK | 0.61105475 |
| 76 | PRKACB | 0.60390254 |
| 77 | MAP2K1 | 0.59902527 |
| 78 | PDPK1 | 0.58728480 |
| 79 | EPHA2 | 0.58414058 |
| 80 | TGFBR2 | 0.55696109 |
| 81 | IRAK3 | 0.55649084 |
| 82 | CAMK1D | 0.53587731 |
| 83 | PBK | 0.52895264 |
| 84 | AKT3 | 0.51298638 |
| 85 | CSNK1D | 0.51175553 |
| 86 | IKBKE | 0.50582081 |
| 87 | EIF2AK1 | 0.50178440 |
| 88 | SGK3 | 0.49820109 |
| 89 | CSNK1E | 0.49716495 |
| 90 | TAOK2 | 0.49484113 |
| 91 | PRKG1 | 0.49252687 |
| 92 | PRKCQ | 0.48821794 |
| 93 | GRK1 | 0.48643956 |
| 94 | PRKG2 | 0.47969720 |
| 95 | TRIM28 | 0.47161162 |
| 96 | CSNK2A2 | 0.46945117 |
| 97 | NLK | 0.45304090 |
| 98 | MAPK7 | 0.43552612 |
| 99 | CSF1R | 0.43116095 |
| 100 | MAP3K5 | 0.43030892 |
| 101 | ICK | 0.42908457 |
| 102 | STK4 | 0.42854385 |
| 103 | PRKCB | 0.42691116 |
| 104 | TNIK | 0.42580641 |
| 105 | FGFR3 | 0.42498252 |
| 106 | MAP3K2 | 0.42429124 |
| 107 | NEK6 | 0.42157847 |
| 108 | MAP3K1 | 0.41986597 |
| 109 | CSNK2A1 | 0.40792185 |
| 110 | CDK4 | 0.40644166 |
| 111 | EPHB2 | 0.40332686 |
| 112 | RPS6KB1 | 0.40072749 |
| 113 | BMX | 0.37540620 |
| 114 | IGF1R | 0.37152845 |
| 115 | MAP3K6 | 0.37078688 |
| 116 | RET | 0.36662950 |
| 117 | PRKCE | 0.34976978 |
| 118 | PDK1 | 0.34795981 |
| 119 | NEK1 | 0.34708453 |
| 120 | CSNK1G1 | 0.34360265 |
| 121 | CSNK1A1 | 0.34110162 |
| 122 | MAPKAPK3 | 0.32793509 |
| 123 | PDGFRB | 0.32761180 |
| 124 | EGFR | 0.32405458 |
| 125 | EPHA4 | 0.32195173 |
| 126 | DDR2 | 0.31734275 |
| 127 | MTOR | 0.31187615 |
| 128 | PRKACA | 0.30993236 |
| 129 | SRC | 0.30561139 |
| 130 | MAP3K13 | 0.29963605 |
| 131 | PRKD3 | 0.29259569 |
| 132 | PRKCG | 0.29256771 |
| 133 | PRKCA | 0.28768202 |
| 134 | PAK3 | 0.27907469 |
| 135 | NUAK1 | 0.27865354 |
| 136 | CDK7 | 0.26956332 |
| 137 | CAMK4 | 0.26869745 |
| 138 | KSR2 | 0.25517103 |
| 139 | OXSR1 | 0.25051197 |
| 140 | STK16 | 0.24112001 |
| 141 | MAP4K1 | 0.24007455 |
| 142 | CAMK2D | 0.21745492 |
| 143 | SGK2 | 0.21705408 |
| 144 | WEE1 | 0.21270606 |
| 145 | AKT2 | 0.20076939 |
| 146 | PIK3CA | 0.18767760 |
| 147 | PKN1 | 0.18287297 |
| 148 | TAOK1 | 0.16592980 |
| 149 | CLK1 | 0.14889045 |
| 150 | PRKCI | 0.14340605 |
| 151 | NME1 | 0.13457986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32577949 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57480648 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30251212 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29946073 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.10994131 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74139307 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65277065 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64552454 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62192151 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50665041 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49923343 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30374735 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18532119 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10289659 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08726290 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03163120 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96655262 |
| 18 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88764557 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88598563 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86163986 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83294636 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82383586 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80017034 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73368323 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70680900 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69779129 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68325455 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67946041 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64293295 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64115026 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61636639 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.58118498 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56650599 |
| 34 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56442163 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54049686 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52537158 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43448706 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42649540 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40486437 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39081837 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38085837 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36577654 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33363395 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29633959 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23216984 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22267841 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.19150713 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18288290 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16504516 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14767280 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06546411 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03837686 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01403174 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00735686 |
| 55 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97408258 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94863521 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93586441 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93335216 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88270420 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79766620 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.78919827 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77068297 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76652753 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74062153 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67635487 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67156433 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65051062 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54615616 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52921541 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50668114 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47060840 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41166913 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34180511 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29854190 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.26583029 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26376692 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.22728190 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22212109 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21426599 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20201385 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19034664 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17586691 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13115130 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07408653 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05829941 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05108348 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.02082582 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01479229 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.00192590 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2485016 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2073140 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2045084 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | -0.2018556 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1945605 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1896530 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1849180 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1734430 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1477003 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1476030 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1475999 |
| 101 | Tight junction_Homo sapiens_hsa04530 | -0.1369002 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1350088 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1248198 |
| 104 | Lysosome_Homo sapiens_hsa04142 | -0.1198353 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1127767 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1117496 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.1066263 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0864345 |
| 109 | Pertussis_Homo sapiens_hsa05133 | -0.0672447 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0351006 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0207522 |

